Homocystine Levels, Polymorphisms and the Risk of Ischemic Stroke in Young Asian Indians

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 2, 2009, Pages 103-110

  Biswas, Arijit ^a   Ranjan, Ravi ^a   Meena, Arvind ^a   Akhter, Mohammad Suhail ^a   Yadav, Birendra Kumar ^a   Munisamy, Murali ^a   Subbiah, Vivekanandhan ^a   Behari, Madhuri ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

ACUTE DISEASE; ADULT; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; ASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; FOLIC ACID BLOOD LEVEL; FOLLOW UP; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; INDIAN; MAJOR CLINICAL STUDY; NUTRITIONAL DEFICIENCY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGE DISTRIBUTION; AGE FACTORS; CONTINENTAL POPULATION GROUPS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HOMOCYSTINE; HUMANS; HYPERHOMOCYSTEINEMIA; INDIA; MALE; MALNUTRITION; POLYMORPHISM, GENETIC; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 60749105806     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.09.014     Document Type: Article

References (40)

1. Lentz S.R. Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 5 (1998) 343-349
2. Ebbesen L.S. Hyperhomocysteinemia, thrombosis and vascular biology. Cell Mol Biol 50 (2004) 917-930
3. Undas A., Brozek J., and Szczeklik A. Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 94 (2005) 907-915
4. Nishinaga M., Ozawa T., and ShimadaHomocysteine K. a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 92 (1993) 1381-1386
5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. J Am Med Assoc 288 (2002) 2015-2022
6. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
7. Nygard O., Nordrehaug J.E., Refsum H., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-237
8. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
9. Arnesen E., Refsum H., Bonaa K.H., et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 24 (1995) 704-709
10. Tanne D., Haim M., Goldbourt U., et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 34 (2003) 632-636
11. Eikelboom J.W., Lonn E., Genest Jr. J., et al. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 363-375
12. Bautista L.E., Arenas I.A., Penuela A., et al. Total plasma homocysteine level and risk of cardiovascular disease: A meta-analysis of prospective cohort studies. J Clin Epidemiol 55 (2002) 882-887
13. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 277 (1997) 1775-1781
14. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288 (2002) 2015-2022
15. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
16. Ford E.S., Smith S.J., Stroup D.F., et al. Homocyst(e)ine and cardiovascular disease: A systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31 (2002) 59-70
17. Lonn E., Yusuf S., Arnold M.J., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
18. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
19. Spence J.D., Howard V.J., Chambless L.E., et al. Vitamin Intervention for Stroke Prevention (VISP) trial: Rationale and design. Neuroepidemiology 20 (2001) 16-25
20. Ntaios G.C., Savopoulos C.G., Chatzinikolaou A.C., et al. Vitamins and stroke: The homocysteine hypothesis still in doubt. Neurologist 14 (2008) 2-4
21. Ho G.Y., Eikelboom J.W., Hankey G.J., et al. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients. Stroke 37 (2006) 456-460
22. Jones W.J., Williams L.S., and Meschia J.F. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke 32 (2001) 2232-2236
23. Zhang Z., Shi Q., Liu Z., et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 1188-1193
24. Friedman G., Goldschmidt N., Friedlander Y., et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr 129 (1999) 1656-1661
25. Naushad S., Jamal N.J., Angalena R., et al. Hyperhomocysteinemia and the compound heterozygous state for methylenetetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul Fibrinolysis 18 (2007) 113-117
26. Narayanasamy A., Subramaniam B., Karunakaran C., et al. Hyperhomocysteinemia and low methionine stress are risk factors for centralretinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci 48 (2007) 1441-1446
27. Bhargava S., Parakh R., Manocha A., et al. Prevalence of hyperhomocysteinemia in vascular disease: Comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease. Vascular 15 (2007) 149-153
28. Fallon U.B., Virtamo J., Young I., et al. Homocysteine and cerebral infarction in Finnish male smokers. Stroke 34 (2003) 1359-1363
29. Eikelboom J.W., Hankey G.J., Anand S.S., et al. Association between high homocysteine and ischemic stroke due to large and small artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 (2000) 1069-1075
30. Meiklejohn D.J., Vickers M.A., Dijkhuisen R., et al. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32 (2001) 57-62
31. Modi M., Prabhakar S., Majumdar S., et al. Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario. Neurol India 53 (2005) 297-301
32. Saraswathy K.N., Mukhopadhyay R., Sinha E., et al. MTHFR C677T polymorphisms among the Ahirs and Jats of Haryana (India). Am J Hum Biol 20 (2008) 116-117
33. Angeline T., Jeyaraj N., Granito S., et al. Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol 77 (2004) 85-88
34. Kumar J., Das S.K., Sharma P., et al. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 50 (2005) 655-663
35. Kalita J., Srivastava R., Bansal V., et al. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Nurol India 54 (2006) 260-263
36. Panigrahi I., Chatterjee T., Biswas A., et al. Role of MTHFR C677T polymorphism in ischemic stroke. Eurol India 54 (2006) 48-50
37. Banerjee I., Gupta V., and Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: A meta-analysis. J Hum Genet 52 (2007) 205-219
38. Ariyaratnam R., Casas J.P., Whittaker J., et al. Genetics of ischemic stroke among persons of non-European descent: A meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 4 (2007) 131
39. Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
40. Ho G.Y., Eikelboom J.W., Hankey G.J., et al. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients. Stroke 37 (2006) 456-460